biosimilars

A proposal for biosimilar reimbursement sparks outrage
Pharmalot
Wed, 10/14/15 - 09:59 am
biosimilars
CMS
reimbursement
Baxalta joins biosim makers eyeing a piece of AbbVie's Humira
Fierce Pharma Marketing
Mon, 10/12/15 - 09:35 am
Baxalta
AbbVie
Humira
biosimilars
Amgen Turning the Tables on 'Generic' Competition
Motley Fool
Wed, 10/7/15 - 09:59 am
Amgen
biosimilars
generics
patents
R&D
Chasing a ghost: Why is FDA guidance on biosim interchangeability taking so long?
BioPharma Dive
Fri, 10/2/15 - 11:40 am
FDA
biosimilars
Amgen Wants Patent Dance Redo and a Halt to Hospira’s EPOGEN Biosimilar
FDA Law Blog
Thu, 09/24/15 - 09:01 am
Amgen
patents
Hospira
biosimilars
Epogen
AbbVie Not Worried About Humira Biosimilars
Bidness, ETC
Mon, 09/21/15 - 10:54 am
AbbVie
Humira
biosimilars
Gilead
Pfizer
Novartis
Amgen
Why is Novartis' Copaxone copy lagging? It's all about coverage, analyst explains
Fierce Pharma
Fri, 09/11/15 - 05:53 pm
Novartis
Copaxone
MS
multiple sclerosis
biosimilars
Teva
Glatopa
First 'biosimilar' drug launches in the US, years after other countries
Yahoo/AP
Thu, 09/10/15 - 06:04 pm
biosimilars
Sandoz
Zarxio
Neupogen
Amgen
Merck and Samsung notch their first biosimilar victory with Enbrel knockoff
Fierce Biotech
Wed, 09/9/15 - 10:42 am
Merck
Samsung Bioepis
Enbrel
biosimilars
Amgen
rheumatoid arthritis
You Don't Have to Wait for the Next Big Thing in Biotech -- It's Already Here
Motley Fool
Mon, 09/7/15 - 11:35 am
biosimilars
Sandoz: Zarxio marketing to be similar to a branded-drug launch
Fierce Pharma Marketing
Thu, 09/3/15 - 06:46 pm
Sandoz
Zarxio
biosimilars
Novartis
drug launches
Amgen
Neupogen
Novartis launches first U.S. 'biosimilar' drug at 15 pct discount
Yahoo/Reuters
Thu, 09/3/15 - 08:45 am
Novartis
biosimilars
Amgen
Neupogen
Zarxio
Sandoz
Amgen cannot stop imminent sale of Neupogen copycat: US appeals court
Yahoo/Reuters
Wed, 09/2/15 - 12:37 pm
Amgen
Neupogen
biosimilars
Zarxio
Novartis
Sandoz
Lilly, Boehringer amp up fight against Lantus with U.K. biosim launch
Fierce Pharma
Sat, 08/29/15 - 08:57 am
Lantus
Eli Lilly
biosimilars
diabetes
Boehringer Ingelheim
Sanofi
FDA's new draft guidance on naming biosimilars already drawing pushback
BioPharma Dive
Fri, 08/28/15 - 12:00 pm
FDA
drug names
biosimilars
What to Call Biologic Copycats? FDA Proposes Names With Suffixes
Bloomberg
Thu, 08/27/15 - 10:05 am
drug names
biosimilars
FDA
Amgen: Waiting for Clarity on Generic Biotech
Barron's
Fri, 08/21/15 - 11:05 am
Amgen
generics
biosimilars
Novartis
Sandoz
Neupogen
Zarxio
AbbVie And Amgen Threatened By Biosimilars
Bidness, ETC
Mon, 08/17/15 - 07:57 am
AbbVie
Amgen
biosimilars
JNJ
Sandoz
Novartis
Humira
Neupogen
Remicade
Nuelasta
Enbrel
epoetin-alfa
Most docs are in the dark about biosimilars: survey
Medical Marketing and Media
Thu, 08/13/15 - 06:22 pm
biosimilars
physicians
Amgen: What If Generic Neulasta Gets Delayed Until Next Year?
Barron's
Wed, 08/12/15 - 12:49 pm
Neulasta
generics
Amgen
Apex Labs
biosimilars

Pages